RIGL icon

Rigel Pharmaceuticals
RIGL

Overview Fund Activity

120 hedge funds and large institutions have $187M invested in Rigel Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 11 closing their positions.

Holders
120
Holders Change
–
Holders Change %
0%
% of All Funds
3.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
43
Reduced
36
Closed
11
Calls
$524K
Puts
$242K
Net Calls
+$282K
Net Calls Change
+$255K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$3.54M
2
GTC
2
Ghost Tree Capital
New York
$1.78M
3
BC
3
Boxer Capital
California
$1.56M
4
SM
4
Sabby Management
Florida
$972K
5
JGC
5
J. Goldman & Co
New York
$1.63M

Top Sellers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$0
2
TC
2
TFS Capital
Pennsylvania
$517K
3
SCM
3
Sio Capital Management
New York
$2.97M
4
SIM
4
Spark Investment Management
New York
$168K
5
SAM
5
Senzar Asset Management
New York
$3.22M
Name Holding Trade Value Shares
Change 		Shares
Change %
SCM
126
Stevens Capital Management
Pennsylvania
– -$33K -1,586 Closed
CSS
127
Cubist Systematic Strategies
Connecticut
– -$28K -1,350 Closed
UMA
128
USA Mutuals Advisors
Texas
– -$2K -78 Closed
2 3 4 5
6